Ziagen, (1S,cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]- 2-cyclopentene-1-methanol, was synthesized from (1S,4R)-azabicyclo[2.2.1]hept-5-en-3-one by efficient processes which bypass problematic steps in earlier routes. 2-Amino-4,6-dichloro-5-formamidopyrimidine is a key intermediate which makes possible an efficient construction of the purine from a chiral cyclopentenyl precursor.

No abstract

No abstract

A C-15 ester substituent is required for significant antileukemic activity among the glaucarubolone ester quassinoids, and variations in the ester group are not accompanied by particularly marked changes in antileukemic activity. Unsaturation at the 3,4 position is advantageous for optimal activity, and hydrogenation of this double bond results in marked diminution in both cytotoxicity toward KB cells in tissue culture and inhibitory activity against the P-388 lymphocytic leukemia in mice.

A systematic increase of substitution rates by tert-butylamine on alpha-bromopropiophenones is observed with meta or para substituents with increasing electron-withdrawing ability (k x 10(3) L M(-1) min(-1) = 12.7 (p-CH(3)), 15.7 (o-F), 20.5 (H), 20.0 (p-Cl), 23.6 (m-Cl), 27.3 (p-CF(3))). Within an ortho-substituted series, the reactivities decrease (k x 10(3) L M(-1) min(-1) = 7.64 (o-OCH(3)), 5.31 (o-CH(3)), 2.85 (o-Cl), 2.40 ( o-CF(3))). Ortho-substitution results occur from rotational barrier effects and an Adelta(sigma)+ Bdelta(sigma)+ repulsion. The major bonding contribution between reaction and alpha-substituent centers (A-B) is only the sigma bond. When pi bonding is allowed between A and B (meta/para-substitution), delocalization and stabilization of the reacting center occurs.